The nature of cancer control is changing, with an increasing emphasis, fuelled by public and
political demand, on prevention, early diagnosis, and patient experience during and after …

Much time, effort and investment goes into the diagnosis of symptomatic cancer, with the
expectation that this approach brings clinical benefits. This investment of resources has …

Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

Rethinking diagnostic delay in cancer: how difficult is the diagnosis? Page 1 Rethinking
diagnostic delay in cancer: how difficult is the diagnosis? OPEN ACCESS Georgios …

Background The faecal immunochemical test (FIT) was introduced to triage patients with low-
risk symptoms of possible colorectal cancer in English primary care in 2017, underpinned by …

Background Thrombocytosis (raised platelet count) is an emerging risk marker of cancer, but
the association has not been fully explored in a primary care context. Aim To examine the …

Background Early identification of cancer in primary care is important and challenging. This
study examined the diagnostic utility of inflammatory markers (C-reactive protein, erythrocyte …

There remains a lack of consensus among guideline relating to which patients require
investigation for haematuria. We determined the incidence of urinary tract cancer in a …

Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is
an important, and modifiable, part of the patient's cancer pathway, and can be affected by …

Objectives The International Cancer Benchmarking Partnership (ICBP) is a collaboration
between 6 countries and 12 jurisdictions with similar primary care-led health services. This …